(CELU) – Corporate News
-
Celularity (CELU) Receives Healthcare Common Procedure Coding System Q Code Approval from the U.S. Centers for Medicare & Medicaid Services for Biovance 3L
-
Celularity (CELU) Submits FDA Request for Orphan Drug Designation for PDA-002
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to CELU Stock Lookup